NEW YORK, Aug. 15, 2025 /PRNewswire/ -- FanDuel, North America's premier online gaming company, today announced a new market access agreement with St. Louis CITY...
FRANKLIN, Mass., Aug. 15, 2025 /PRNewswire/ -- Barrett Distribution Centers is proud to announce a new partnership with FCTRY LAb, a trend-setting footwear company...
LOS ANGELES, Aug. 15, 2025 /PRNewswire/ -- Based on Naoya Matsumoto's hit manga series Kaiju No. 8, serialized on Shueisha's Shonen Jump+ and with over 18...
The new haircare device features atomizing essence nourishment, red light therapy, and a 130,000 RPM high-speed motor for optimal hair and scalp health and...
LOS ANGELES, Aug. 15, 2025 /PRNewswire/ -- "Empowered with Meg Ryan" joins forces with the Charlotte Rescue Mission to explore the profound impact of...
Crackd, the UK's #1 selling plant-based egg product, announces that it is now being stocked in major grocery stores in Chicago and throughout Texas. ...
LOS ANGELES, Aug. 14, 2025 /PRNewswire/ -- Lido Advisors, a fast-growing national wealth advisory firm with more than $30 billion in RAUM*, today announced...
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.